医学
开颅术
重症监护室
并发症
外科
麻醉
术后恶心呕吐
呕吐
恶心
后颅窝
入射(几何)
重症监护医学
光学
物理
作者
L. Lonjaret,Marine Guyonnet,Emilie Bérard,Marc Vironneau,Françoise Peres,S. Sacrista,Anne Ferrier,Véronique Ramonda,Corine Vuillaume,Franck‐Emmanuel Roux,Olivier Fourcade,Thomas Geeraerts
标识
DOI:10.1016/j.accpm.2016.06.012
摘要
After elective craniotomy for brain tumour surgery, patients are usually admitted to an intensive care unit (ICU) for monitoring. Our goal was to evaluate the incidence and timing of neurologic and non-neurologic postoperative complications after brain tumour surgery, to determine factors associated with neurologic events and to evaluate the timing and causes of ICU readmission. This prospective, observational and analytic study enrolled 188 patients admitted to the ICU after brain tumour surgery. All postoperative clinical events during the first 24 hours were noted and classified. Readmission causes and timing were also analysed. Twenty-one (11%) of the patients were kept sedated after surgery; the remaining 167 patients were studied. Thirty one percent of the patients presented at least one complication (25% with postoperative nausea and vomiting (PONV), 16% with neurologic complications). The occurrence of neurological complications was significantly associated with the absence of preoperative motor deficit and the presence of higher intraoperative bleeding. Seven patients (4%) were readmitted to the ICU after discharge; 43% (n = 3) of them had a posterior fossa surgery. Postoperative complications, especially PONV, are frequent after brain tumour surgery. Moreover, 16% of patients presented a neurological complication, probably justifying the ICU postoperative stay for early detection. The absence of preoperative motor deficit and intraoperative bleeding seems to predict postoperative neurologic complications. Finally, patients may present complications after ICU discharge, especially patients with fossa posterior surgery, suggesting that ICU hospitalization may be longer in this type of surgery.
科研通智能强力驱动
Strongly Powered by AbleSci AI